Regencell Bioscience Holdings Ltd (RGC)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 06/30
| 06-2007 | 03-2007 | 12-2006 | 09-2006 | 06-2006 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 281,800 | 229,100 | 86,300 | 57,100 | 27,800 |
| Depreciation Amortization | 92,400 | 46,300 | 197,100 | 149,500 | 100,400 |
| Income taxes - deferred | -46,800 | -44,800 | -19,800 | -10,100 | -4,800 |
| Accounts receivable | 36,900 | 38,500 | -3,500 | 24,200 | 22,300 |
| Accounts payable and accrued liabilities | -32,500 | -20,000 | -13,200 | -86,800 | -25,800 |
| Other Working Capital | 332,900 | 469,500 | -40,600 | -110,500 | -47,200 |
| Other Operating Activity | -21,400 | -8,600 | 98,100 | 132,700 | 63,100 |
| Operating Cash Flow | $643,300 | $710,000 | $304,400 | $156,100 | $135,800 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -47,000 | -16,800 | -117,600 | -78,400 | -50,400 |
| Net Acquisitions | -1,500 | -1,500 | -34,100 | -34,100 | N/A |
| Sale Of Investment | 28,300 | N/A | N/A | N/A | N/A |
| Investing Cash Flow | $-20,200 | $-18,300 | $-151,700 | $-112,500 | $-50,400 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | N/A | N/A | 140,400 | 100,000 | 100,000 |
| Debt Issued | N/A | N/A | 17,900 | 17,300 | 16,100 |
| Debt Repayment | -11,700 | -6,200 | -172,700 | -162,000 | -145,700 |
| Common Stock Issued | 14,800 | 3,200 | 16,100 | 12,400 | 11,900 |
| Dividend Paid | -393,200 | -45,300 | -179,600 | -134,500 | -89,500 |
| Other Financing Activity | 11,700 | 2,100 | -8,900 | 6,900 | 6,700 |
| Financing Cash Flow | $-378,400 | $-46,200 | $-186,800 | $-159,900 | $-100,500 |
| Beginning Cash Position | 162,200 | 162,200 | 196,300 | 196,300 | 196,300 |
| End Cash Position | 406,900 | 807,700 | 162,200 | 80,000 | 181,200 |
| Net Cash Flow | $244,700 | $645,500 | $-34,100 | $-116,300 | $-15,100 |
| Free Cash Flow | |||||
| Operating Cash Flow | 643,300 | 710,000 | 304,400 | 156,100 | 135,800 |
| Capital Expenditure | -57,800 | -19,900 | -124,700 | -84,700 | -55,400 |
| Free Cash Flow | 585,500 | 690,100 | 179,700 | 71,400 | 80,400 |